Table 2:
Associations of FPG with all-cause and cardiovascular disease mortality.
| Model 1a | Model 2b | Model 3c | Model 4d | |||||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
| All-cause mortality | ||||||||
| Continuous FPG | 1.13 (1.11–1.16) | <.001 | 1.07 (1.04–1.10) | <.001 | 1.01 (0.97–1.05) | .655 | 0.99 (0.95–1.04) | .769 |
| FPG categories | ||||||||
| FPG <5.6 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 5.6 ≤ FPG < 7.0 | 1.76 (1.35–2.30) | <.001 | 1.13 (0.89–1.43) | .313 | 0.87 (0.65–1.16) | .342 | 0.87 (0.65–1.16) | .342 |
| FPG ≥7.0 | 3.23 (2.66–3.91) | <.001 | 1.70 (1.39–2.09) | <.001 | 0.93 (0.70–1.25) | .638 | 0.93 (0.70–1.25) | .638 |
| P for trend test | <.001 | <.001 | .629 | .629 | ||||
| Cardiovascular disease mortality | ||||||||
| Continuous FPG | 1.13 (1.10–1.17) | <.001 | 1.06 (1.02–1.10) | .005 | 1.01 (0.96–1.07) | .643 | 1.01 (0.95–1.06) | .985 |
| FPG categories | ||||||||
| FPG <5.6 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 5.6 ≤ FPG < 7.0 | 1.69 (1.21–2.34) | .002 | 1.12 (0.80–1.56) | .510 | 0.99 (0.67–1.45) | .984 | 0.99 (0.67–1.48) | .971 |
| FPG ≥7.0 | 3.32 (2.53–4.37) | <.001 | 1.67 (1.25–2.23) | .001 | 1.18 (0.81–1.74) | .375 | 1.09 (0.73–1.63) | .671 |
| P for trend test | <.001 | .002 | .629 | .896 | ||||
a
Unadjusted model.
b
Adjusted for age, gender, BMI.
c
Adjusted for age, gender, BMI, TC, TG, corrected calcium, phosphorus, CCI, hemoglobin, albumin, uric acid, RRF, hs-CRP level and glucose load.
d
Adjusted for age, gender, BMI, TC, TG, corrected calcium, phosphorus, CCI, hemoglobin, albumin, uric acid, RRF, hs-CRP level, glucose load and hypoglycemic treatment.
P < .05 is considered statistically significant. Data shown in bold-type means P < 0.05.